Labcorp Holdings Inc.
LH
$259.93
$4.181.63%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.14B | 13.95B | 13.77B | 13.48B | 13.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.14B | 13.95B | 13.77B | 13.48B | 13.18B |
| Cost of Revenue | 10.07B | 9.94B | 9.85B | 9.69B | 9.50B |
| Gross Profit | 4.08B | 4.01B | 3.92B | 3.79B | 3.68B |
| SG&A Expenses | 2.23B | 2.23B | 2.27B | 2.29B | 2.27B |
| Depreciation & Amortization | 286.00M | 280.00M | 277.80M | 272.00M | 265.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.58B | 12.45B | 12.40B | 12.25B | 12.04B |
| Operating Income | 1.56B | 1.51B | 1.36B | 1.23B | 1.14B |
| Income Before Tax | 1.15B | 1.11B | 1.10B | 974.30M | 937.30M |
| Income Tax Expenses | 209.30M | 229.80M | 244.30M | 209.80M | 205.50M |
| Earnings from Continuing Operations | 942.70 | 877.70 | 856.40 | 764.50 | 731.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.20M | -1.20M | -1.20M | -1.10M | -1.00M |
| Net Income | 941.50M | 876.50M | 855.20M | 763.40M | 730.80M |
| EBIT | 1.56B | 1.51B | 1.36B | 1.23B | 1.14B |
| EBITDA | 2.25B | 2.19B | 2.05B | 1.91B | 1.80B |
| EPS Basic | 11.37 | 10.54 | 10.26 | 9.13 | 8.72 |
| Normalized Basic EPS | 10.02 | 9.64 | 8.76 | 7.90 | 7.44 |
| EPS Diluted | 11.28 | 10.45 | 10.19 | 9.07 | 8.66 |
| Normalized Diluted EPS | 9.95 | 9.57 | 8.69 | 7.85 | 7.40 |
| Average Basic Shares Outstanding | 331.30M | 332.60M | 333.70M | 334.60M | 335.30M |
| Average Diluted Shares Outstanding | 333.70M | 335.10M | 336.10M | 336.80M | 337.20M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 25.52% | 27.46% | 28.24% | 31.71% | 33.20% |